Fora Capital, LLC Horizon Therapeutics Public LTD CO Transaction History

Fora Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$96.34 - $112.38 $115,800 - $135,080	-1,202 Reduced 4.32%	26,640 $2.74 Million
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $2.99 Million - $3.16 Million	27,842 New	27,842 $3.04 Million
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $389,509 - $473,884	-3,952 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $404,955 - $486,290	-4,406 Reduced 52.72%	3,952 $433,000
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $720,793 - $801,699	8,358 New	8,358 $783 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.